Fairmount Funds Management LLC, Director, 10% Owner at CRESCENT BIOPHARMA, INC., bought $7.6M of CBIO
This page documents an SEC Form 4 insider trading disclosure for $CBIO securities filed with the Securities and Exchange Commission. Section 16 of the Securities Exchange Act of 1934 mandates that corporate officers, directors, and beneficial owners of more than 10% of a company's registered equity securities must report their personal trades within two business days of execution. Insider transactions are closely monitored by market participants because insiders possess firsthand knowledge of company operations, financial condition, and near-term prospects. The transaction details below are drawn directly from the SEC EDGAR filing database and reflect the information as reported.
Transaction Details
| Insider | Fairmount Funds Management LLC |
|---|---|
| Title | Director, 10% Owner |
| Company | CRESCENT BIOPHARMA, INC. |
| Ticker | CBIO |
| Transaction Type | Purchase |
| Transaction Date | 2026-07-16 |
| Shares Traded | 525,897 |
| Price Per Share | $14.499 |
| Total Value | $7.6M |
| Filed Date | 2026-07-20 |
| Accession Number | 0001104659-26-085113 |
Ownership Context
| Shares Owned After Transaction | — |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001104659-26-085113
Other Insider Trades — CBIO
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Fairmount Funds Management LLC | Director, 10% Owner | bought | $12.4M | 2026-07-16 |
| Pinkas Jan | Chief Scientific Officer | sold | $23K | 2026-06-22 |
| Scalzo Richard William | Chief Financial Officer | sold | $20K | 2026-06-22 |
| Bispham Barbara Harlin | See Remarks | sold | $22K | 2026-06-22 |
| Im Ellie Eunkyung | Chief Medical Officer | sold | $22K | 2026-06-22 |
| McNeill Jonathan | President and COO | sold | $370K | 2026-06-22 |
| Brumm Joshua T | Chief Executive Officer, Director | sold | $761K | 2026-06-22 |
| Lynch Ryan | See Remarks | sold | $8K | 2026-06-22 |
| Lubner David Charles | Director | traded | — | 2026-06-02 |
| Balcom Alexandra | Director | traded | — | 2026-06-02 |
Other Trades by Fairmount Funds Management LLC
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| APGE | Apogee Therapeutics, Inc. | traded | $455K | 2026-08-07 |
| APGE | Apogee Therapeutics, Inc. | traded | $541K | 2026-08-07 |
| CBIO | CRESCENT BIOPHARMA, INC. | bought | $12.4M | 2026-07-16 |
| ORKA | Oruka Therapeutics, Inc. | sold | $300.0M | 2026-07-01 |
| ORKA | Oruka Therapeutics, Inc. | traded | — | 2026-07-01 |
| ORKA | Oruka Therapeutics, Inc. | traded | — | 2026-07-01 |
| SYRE | Spyre Therapeutics, Inc. | traded | — | 2026-06-23 |
| SYRE | Spyre Therapeutics, Inc. | traded | — | 2026-06-23 |
| SYRE | Spyre Therapeutics, Inc. | sold | $399.7M | 2026-06-23 |
| JBIO | Jade Biosciences, Inc. | traded | — | 2026-06-09 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for CBIO — CRESCENT BIOPHARMA, INC. →
Whisper Score — CBIO
Track CBIO insider activity in real time on The Wire →
Get alerts when Fairmount Funds Management LLC files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: August 12, 2026 at 07:06 UTC